Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
The Cooper Companies Inc is a medical instruments & supplies business based in the US. The Cooper Companies shares (COO) are listed on the NYSE and all prices are listed in US Dollars. The Cooper Companies employs 12,000 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$439.34|
|52-week range||$314.24 - $463.59|
|50-day moving average||$437.18|
|200-day moving average||$403.94|
|Wall St. target price||$478.50|
|Dividend yield||$0.06 (0.01%)|
|Earnings per share (TTM)||$58.68|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-09-17)||0.63%|
|1 month (2021-08-24)||-1.89%|
|3 months (2021-06-24)||12.48%|
|6 months (2021-03-24)||15.52%|
|1 year (2020-09-24)||33.53%|
|2 years (2019-09-24)||46.97%|
|3 years (2018-09-24)||63.06%|
|5 years (2016-09-23)||142.77%|
Valuing The Cooper Companies stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of The Cooper Companies's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
The Cooper Companies's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 7x. In other words, The Cooper Companies shares trade at around 7x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
The Cooper Companies's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.6754. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into The Cooper Companies's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
The Cooper Companies's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $924.9 million.
The EBITDA is a measure of a The Cooper Companies's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$2.8 billion|
|Operating margin TTM||21.65%|
|Gross profit TTM||$1.6 billion|
|Return on assets TTM||4.71%|
|Return on equity TTM||55.29%|
|Market capitalisation||$21.5 billion|
TTM: trailing 12 months
There are currently 1.7 million The Cooper Companies shares held short by investors – that's known as The Cooper Companies's "short interest". This figure is 20.2% up from 1.4 million last month.
There are a few different ways that this level of interest in shorting The Cooper Companies shares can be evaluated.
The Cooper Companies's "short interest ratio" (SIR) is the quantity of The Cooper Companies shares currently shorted divided by the average quantity of The Cooper Companies shares traded daily (recently around 261132.97045101). The Cooper Companies's SIR currently stands at 6.43. In other words for every 100,000 The Cooper Companies shares traded daily on the market, roughly 6430 shares are currently held short.
However The Cooper Companies's short interest can also be evaluated against the total number of The Cooper Companies shares, or, against the total number of tradable The Cooper Companies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case The Cooper Companies's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 The Cooper Companies shares in existence, roughly 30 shares are currently held short) or 0.0343% of the tradable shares (for every 100,000 tradable The Cooper Companies shares, roughly 34 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against The Cooper Companies.
Find out more about how you can short The Cooper Companies stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like The Cooper Companies.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 18.29
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and The Cooper Companies's overall score of 18.29 (as at 12/31/2018) is pretty good – landing it in it in the 24th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like The Cooper Companies is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 4.6/100
The Cooper Companies's environmental score of 4.6 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that The Cooper Companies is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 8.68/100
The Cooper Companies's social score of 8.68 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that The Cooper Companies is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 5.5/100
The Cooper Companies's governance score puts it squarely in the 2nd percentile of companies rated in the same sector. That could suggest that The Cooper Companies is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 1/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. The Cooper Companies scored a 1 out of 5 for controversy – the highest score possible, reflecting that The Cooper Companies has managed to keep its nose clean.
|Total ESG score||18.29|
|Total ESG percentile||23.8|
|Environmental score percentile||2|
|Social score percentile||2|
|Governance score percentile||2|
|Level of controversy||1|
Dividend payout ratio: 0.46% of net profits
Recently The Cooper Companies has paid out, on average, around 0.46% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.01% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), The Cooper Companies shareholders could enjoy a 0.01% return on their shares, in the form of dividend payments. In The Cooper Companies's case, that would currently equate to about $0.06 per share.
While The Cooper Companies's payout ratio might seem low, this can signify that The Cooper Companies is investing more in its future growth.
The Cooper Companies's most recent dividend payout was on 10 August 2021. The latest dividend was paid out to all shareholders who bought their shares by 25 July 2021 (the "ex-dividend date").
The Cooper Companies's shares were split on a 2:1 basis on 24 November 2002. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your The Cooper Companies shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for The Cooper Companies shares which in turn could have impacted The Cooper Companies's share price.
Over the last 12 months, The Cooper Companies's shares have ranged in value from as little as $314.2425 up to $463.59. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while The Cooper Companies's is 0.833. This would suggest that The Cooper Companies's shares are less volatile than average (for this exchange).
The Cooper Companies, Inc. operates as a medical device company worldwide. It operates through two segments, CooperVision and CooperSurgical. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services for enhancing health of women, babies, and families, including medical devices, fertility, genomics, and diagnostics and contraception for hospitals and surgical centers, obstetricians' and gynecologists' (OB/GYNs) medical offices, and fertility clinics. In addition, the company develops mechanical surgical solutions for skin closure; and offers PARAGARD, a contraceptive, as well as provides assisted reproductive technology products, genetic screening and testing, and products within the general OB/GYN offerings. It markets its products under Biofinity, clariti 1day, MyDay, Avaira Vitality, and Proclear 1 Day brand name through a network of field sales representatives, independent agents, eye care practitioners, and distributors.
Everything we know about the Enfusion IPO, plus information on how to buy in.
Everything we know about the Intuity Medical IPO, plus information on how to buy in.
Everything we know about the Pyxis Oncology IPO, plus information on how to buy in.
Everything we know about the AEON Biopharma IPO, plus information on how to buy in.
Everything we know about the IHS Holding Ltd IPO, plus information on how to buy in.
Everything we know about the BT Brands IPO, plus information on how to buy in.
Everything we know about the Immix IPO, plus information on how to buy in.
Everything we know about the Keter Group SA IPO, plus information on how to buy in.
Everything we know about the Theseus Pharmaceuticals IPO, plus information on how to buy in.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq on Sep. 20, 2021
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.